Skip to content

Vivani Medical VANI Deferred Tax Liabilities, Gross

Deferred Tax Liabilities, Gross at other companies

State Street logo
State StreetSTT
$972M+5.8%
MSCI logo
MSCIMSCI
$245.53M+29.4%
Keysight Technologies logo
Keysight TechnologiesKEYS
$459M+30.0%
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$2.74B+240%
PepsiCo logo
PepsiCoPEP
$4.66B+13.0%
L3Harris Technologies logo
L3Harris TechnologiesLHX
$3.28B-8.9%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilities.

The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's deferred tax liabilities, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's deferred tax liabilities, gross?
Vivani Medical (VANI) reported deferred tax liabilities, gross of $2.14M in Q4 2025.
What is the long-term trend for Vivani Medical's deferred tax liabilities, gross?
Over 3 years (2022 to 2025), Vivani Medical's deferred tax liabilities, gross has grown at a 7.7% compound annual growth rate (CAGR), from $1.71M to $2.14M.